Short-term outcomes of treatment switch to faricimab in patients with aflibercept-resistant neovascular age-related macular degeneration.
Miklos SchneiderJakob BjeragerDelila Hodzic-HadzibegovicOliver Niels KlefterYousif SubhiJavad HajariPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2024)
ClinicalTrials.gov registration number: NCT06124677. Date of registration: 09/11/2023, retrospectively registered.